NHS weight-loss jabs are set to become available in pharmacies over the coming years as part of a plan to boost the nation’s ...

NHS leaders consider phased roll out of Mounjaro obesity jab to combat high demand - Nearly a quarter of a million people are expected to receive the Mounjaro jab over the next three years.

'Obesity is the new smoking', NHS chief to say. Being overweight is the second biggest cause of cancer. Alex Matthews-King. Health Correspondent. Wednesday 14 March 2018 01:20 GMT. Comments.

The type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS. Mounjaro – also known as tirzepatide and made by Eli Lilly – is a glucagon-like peptide-1 ...

But weight-loss specialists warn that NHS obesity services are already struggling to deal with demand for these drugs, and that the injections should only be used as part of a wider treatment plan.

CHILDREN as young as ten have had hip replacements on the NHS because they are so fat, shock figures show. They are going under the knife as childhood obesity levels soar, with one in three now cla… ...

The amount of NHS hospital treatment for obese patients has quadrupled in a decade, new statistics show.. Official figures show almost 1.9 million hospital episodes of treatment for patients with ...

More than 200 doctors and specialists have now written to the health secretary to say how stretched NHS obesity treatment services face unprecedented demand from patients wanting these drugs.

NHS Digital data for England shows there were a record 1.2million hospitalisations where obesity was a factor in 2022/23, double the 617,000 logged in 2016/17.